The aim of the present study was to clarify the role of oxidative stress in streptozotocin induced liver injury and the possible protective effect of caffeic acid phenethyl ester (CAPE) using histological and biochemical parameters. 32 male Wistar rats were divided into 4 groups as follows: Group 1: Control animals, Group 2: Control animals given CAPE Group 3: STZ-induced diabetic animals (DM group), Group 4: STZ-induced diabetic rats given CAPE (DM+CAPE group). All the injections started on the same day of single-dose STZ injection and continued for 20 days. At the end of this period, livers were removed and processed for routine histological procedures. Biochemical parameters and morphological changes were examined. In DM group, blood glucose levels were signifi cantly increased compared with the control group. Signifi cant increases in tissue malondialdehyde (MDA) level and decreases in superoxide dismutase (SOD) and total glutathione (GSH) activities were detected in DM group. Administration of CAPE signifi cantly reduced these values. STZ-induced histopathological alterations including infl ammatory cell infi ltration around portal triad, congestion, loss of glycogen in the hepatocytes. Additionally, degenerative cellular alterations, such as numerous vacuolizations including myelinic fi gure formation, pyknotic nuclei with peripheral localization of heterochromatin condensation and mitochondrial elongation were observed in cytoplasm of hepatocytes. CAPE signifi cantly reduced these histopathological changes. Our results indicate that CAPE should be considered in the prevention of oxidative stress in diabetic liver (Tab. 3, Fig. 4, Ref. 47). Text in PDF www.elis.sk. KEY WORDS: caffeic acid phenethyl ester, streptozotocin, liver.
Introduction
Diabetes mellitus is a group of metabolic disorders with different underlying aetiologies, each characterized by hyperglycemia due to underutilization and/or over production of glucose (1) . Hyperglycemia may cause oxidative stress, which in turn may result in cellular tissue damage (2, 3) . Streptozotocin (STZ) is an established diabetogenic agent in animal models, which induces insulin defi ciency due to its selective pancreatic β-cell cytotoxicity caused by DNA alkylation and nitric oxide (NO) generation (4, 5) . By affecting glycogen and lipid metabolism, diabetes causes structural and functional abnormalities in the liver (6) . Studies have shown that hepatobiliary disorders, such as infl ammation, necrosis and acute liver failure can follow diabetes (7, 8) .
Higher glucose levels increase the production of free radicals and serum concentration of malondialdehyde and conjugated dienes which are markers of cellular damage due to free radicals (9) .
Oxidative stress is an imbalance between the production of free radicals and defence capacity of antioxidants. Oxidative stress is measured by indices of lipid peroxidation (LPO) such as malondialdehyde (MDA), antioxidant enzymes including superoxide dismutase (SOD) and glutathione-S-transferases (GSTs) (10) . Oxidative stress has been documented in hyperglycemia of both type 1 and type 2 diabetes and thus should be regarded as central player in the development of diabetes complications (3) . This notion has been supported by several studies utilizing both diabetic human and animal models (11, 12) .
Caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE) is an active component of honeybee propolis extracts and has been used for many years as a folk medicine. It has anti-infl ammatory, immunomodulatory, antiproliferative and antioxidant properties and has been shown to inhibit lipo-oxygenase activities as well as to suppress lipid peroxidation (13, 14) .
This experimental study was designed to clarify the role of oxidative stress in STZ induced liver injury and the possible protective effect of CAPE using histological and biochemical parameters.
Material and methods
Chemicals. STZ and CAPE were purchased from Pharmacia Company (Sigma, St. Louis, MO).
Animals. 32 Wistar albino male rats were housed in an air-conditioned room with 12-h light and dark cycles, where the tem-perature (22 ± 2 ºC) and relative humidity (65-70 %) were kept constant. All experimental protocols were approved by the Inonu University, School of Medicine Animal Care and Use Committee, Malatya, Turkey.
Experimental Protocol. The Rats were divided into 4 groups randomly, each group including 8 animals. Group 1: Control animals Group 2: Control animals given CAPE Group 3: STZ-induced diabetic animals (DM group) Group 4: STZ-induced diabetic rats given CAPE (DM+CAPE group) Experimental animals were rendered diabetic by an intraperitoneal injection of a single dose STZ (55 mg/kg) dissolved in physiological saline (0.9 % NaCl) (PS) . CAPE (10 μmol/kg) was given by ip to rats for 20 days after the experimental animals were made diabetic. The plasma glucose level was measured; at the start of experiment, 72 hours after administration of injection STZ and after 20 days to ascertain diabetic status of the animals using glucometer. At the end of the 21st day, all the rats were sacrifi ced with ketamine/xylazine anesthesia; their liver tissues were excised.
Histological assessment
The livers of rats were rapidly removed at the end of the experiment and divided to three portions. The fi rst part of the samples were placed in 10% buffered formalin and prepared for routine parafi n embedding. Tissue sections were cut at 5μm, mounted on slides, stained with hematoxylineosin (H-E) for general liver structure, periodic acid schiff (PAS) to demonstrate the glycogen deposition in hepatocytes and toluidin blue to determine the number of mast cells. The sections were examined by a Leica DFC 280 light microscope by a histologists unaware of the status of animals. The liver damage severity was semiquantitatively assessed as follows; mononuclear cell infi ltration, congestion and loss of the glycogen deposition in hepatocytes. Microscopic damage was identifi ed as absent (0), slight (1), moderate (2) , and severe (3), for each criterion. Mast cells were counted in the 10 microscopic under 40X objective magnifi cation using Leica Q Win Image Analysis System (Leica Micros Imaging Solution Ltd. Cambridge, UK). The other parts of the tissues were processed for electron microscopic examination. For that purpose, samples were fi xed in 2.5% glutaraldehyde buffered with 0.2 M NaH 2 PO 4 + NaHPO 4 (pH = 7.2-7.3) and postfi xed in 1 % OsO4. After dehydration in acetone, they were embedded in Araldite CY 212. Ultrathin sections were stained with uranyl acetate and lead citrate and than were examined in a Zeiss Libra 120 electron microscope. The other part was placed in liquid nitrogen and stored at −70 °C until assay for malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD).
Biochemical assessment
The remaining parts of the samples were homogenized in ice-cold 0.1 M Tris-HCI buffer (pH 7.5) (containing protease inhibitor, phenylmethlsulfonyl fl uoride, 1 mM) with a homogenizer (IKA ultra turrax T25 basic) at 16.000 r.p.m. for 2 min at +4-8 ºC.
Measurement of tissue MDA
MDA equivalents in the liver tissue homogenate were determined by the method of Mihara and Uchiyama (15) . Half a milliliter of homogenate was mixed with 3 mL H3PO4 solution (1 % w/v), 1 mL thiobarbituric acid solution (0.67 % w/v) was added and the mixture was heated in a water bath for 45 min at 95 °C. The colored complex that was formed was extracted with n-butanol and the absorbance at 532 nm was measured. Tetramethoxypropane was used as a standard. The amounts of lipid peroxides were calculated and are reported as nmol/mg protein.
Measurement of total glutathione
The formation of 5-thio-2-nitrobenzoate (TNB) was followed spectrophotometrically at 412 nm (16) . The amount of GSH in the extract was determined in nmol/mg protein utilizing a commercial GSH as the standard.
Measurement of tissue SOD
Superoxide dismutase (SOD; copper, zinc-SOD) activity was measured in the supernatant fraction using xanthine oxidase/ cytochrome c method according to the method followed by McCord and Fridovich (17) where one unit of activity is the amount of enzyme needed to cause half-maximal inhibition of cytochrome C reduction. The amount of SOD in the extract was determined in nanograms of enzyme per milligram protein utilizing a commercial SOD as standard.
Determination of protein levels
Protein levels of the tissue samples were measured by the Bradford method (18). The absorbance measurement was taken at 595 nm using a UV-VIS spectrophotometer. Bovine serum albumin (BSA)
Statistical analysis
A computer program (SPSS 11.0) was used for statistical analysis. The results were compared with Kruskal-Wallis variance analysis. Where differences among the groups were detected, group means were compared using the Mann-Whitney U test. Values of p < 0.05 were considered signifi cant. All results were expressed as means ±standard error (SE). In-group change was evaluated by Wilcoxon's paired matched sample test. Results were considered statistically signifi cant at p < 0.05. Table 1 shows the levels of blood glucose in control and experimental groups of rats. Prior to induction of diabetes, the blood glucose levels of all groups were similar. After streptozotocin (STZ) injection, a signifi cant increase was observed in the blood glucose levels of diabetic rats at 20th day compared to day 0 (p < 0.05). CAPE treatment produced signifi cant changes in the blood glucose levels in nondiabetic rats (p < 0.05). The administration of CAPE for 20 days caused a decrease in the level of blood glucose in the diabetic rats.
Results

Blood glucose level
Histological results
Light microscopic evaluation The control and CAPE groups showed a normal appearance of the liver cells (Fig. 1A, B) . However in the DM group, histological alterations were observed such as infl ammatory cell infi ltration around portal triad (Fig. 1C) . In addition, congestion was seen in this group (Fig. 1D) . In DM+CAPE group although the liver tissue preserved it's normal histological apperance, congestion still was marked in some area (Fig. 1E) .
The PAS-positive reaction shows a magenta staining where glycogen is present within hepatocytes in control and CAPE group ( Fig. 2A, B) . The glycogen storage in hepatocytes was observed as decreased in the DM group (Fig. 2C) . On the other hand, CAPE treatment reduced loss of the glycogen in the hepatocytes (Fig.  2D) . Microscopic damage scores are given in Table 2 .
Other remarkable fi nding in the DM group was the increase in the number of mast cell. On the other hand in DM+CAPE group (34.14 ±7 .05) the number of mast cell was found to be significantly decreased when compared with DM group (49.42 ± 15.75) (p < 0.0001) (Fig. 3A, B, C, D Tab. 1. Initial and fi nal blood glucose levels of four groups of eight rats each. 
Tab. 2. The results of semiquantitative histological assessment and the number of mast cells in all groups.
Electron microscopic evaluation Examination of livers obtained from the control and CAPE groups showed normal ultrastructural appearance (Fig. 4A, B) . In the ultrathin sections from livers of DM group, we detected many degenerative alterations in hepatocyte and Kupffer cells, such as numeourus vacuolization including myelinic fi gures formation, mitochondrial elongation (Fig. 4C ), pyknotic nuclei with peripheral localization of heterochromatin condensation. In addition, many lysosomes were present with in the cytoplasm of hepatocytes and Kupffer cells. Also phagocytic bodies were located in the cytoplasm of the hepatocytes in this group (Fig. 4D) . Liver sections of CAPE administered rats were nearly normal in ultrastructural appearances. However, intracytoplasmic vacuolization and lysosomes were rarely seen. (Fig. 4E, F) .
Biochemical results
The levels of MDA and GSH and the activities of SOD of the liver tissue are shown in Table 2 . In the DM group, MDA levels were increased (p < 0.0001). SOD activities and GSH levels were decreased signifi cantly (p < 0.0001) when compared with the control group. MDA levels were decreased in the DM+CAPE groups when compared with the DM group (p < 0.0001). GSH level and SOD activities were increased signifi cantly in the DM+CAPE groups when compared with the DM group (p < 0.0001). These results indicate that CAPE is effectively able to inhibit lipid peroxidation and the production of MDA, and inhibit the need and usage of antioxidant enzymes and/or stimulate the production of antioxidant enzymes in DM-injured liver.
Discussion
In this study, we observed histological and biochemical changes in STZ-induced rats, which were alleviated with CAPE treatment. The STZ-induced diabetic rat is one of the animal models of human diabetes mellitus (19) . STZ is given as a single injection of 40-60 mg/kg to provoke diabetes in rats (20) (21) (22) . We used STZ, an antibiotic produced by Streptomyces achromogenes, at a single dose of 55 mg/kg. This type 1 diabetes mellitus model is characterized by hyperglycemia, hypoinsulinemia, alterations in carbohydrate and lipid metabolism (19) . Hyperglycemia is an important factor in the development and progression of the complications of diabetes mellitus and a good glycemic control is necessary to prevent diabetic complications (23) .
In our study, increased blood glucose concentration during the experimental period clearly indicated the persistent hyperglycemia in the STZ-induced diabetic rats. The administration of CAPE lowered the blood glucose concentration in diabetic rats. In the previous studies, it was shown that blood glucose concentration was decreased by using CAPE (24) .
Caffeic acid phenethyl ester (CAPE), a fl avonoid-like compound, is one of the major components of honeybee propolis. CAPE has no possible harmful effects on normal cells but several biological and pharmacological properties including antioxidant, anti-infl ammatory, anti-carcinogenic, antiviral and immunomodulatory activities. At a concentration of 10 μM, CAPE completely blocks the production of reactive oxygen species in human neutrophils and the xanthine/xanthine oxidase system (13, 25) . The levels of lipid peroxidation and the activities of antioxidant enzymes increase in streptozotocin (STZ)-induced diabetic rats. CAPE was shown to inhibit lipooxygenase activities and suppress lipid peroxidation (14, 27) .
Liver is regarded as one of the central metabolic organs in the body which regulates and maintains homeostasis. It performs most of the reactions involved in the synthesis and utilization of glucose. The balance between glucose production and its utilization in the liver is regulated primarily by insulin. In experimental diabetes, glucose metabolism is remarkably altered. Persistent hyperglycemia is a major contributor to metabolic alterations in the pathogenesis of diabetic complications, especially neuropathy and microvascular disease (36) . This study investigates whether CAPE has protective effects on the STZ-induced liver damage. Hepatocellular damage developed in the liver after STZ administration in rats has been shown by several authors (10, 30) . Vardi et al have reported deterioration in the radial placement of hepatocytes starting from the central veins towards the periphery in the liver and hydropic change in hepatocytes located at the periphery of the lobules (30). Hamadi et al have given an account of STZ, administered as a single dose (60 mg/kg), generating infl ammation, necrosis in the liver of diabetic rats and vacuolisation in hepatocytes (10) . In this study, histological examinations of liver tissues in DM group of rats showed severe histological changes such as mononuclear cell infi ltration, hemorrahage and loss of the glycogen deposition in hepatocytes. The glycogen content in hepatocyte cytoplasm was evaluated via PAS staining method in our study. A signifi cant loss of glycogen was observed in the periphery of the hepatic lobules of the STZadministered groups through this method. Glycogen, which is the main energy source of hepatocytes, is also an important parameter indicating the liver damage.
Loss of glycogen stores in the cells is attributed to the dependence of the cell on glucose because of the deterioration of energy metabolism (31). Ros et al reported that STZ treatment caused a signifi cant decrease in the liver glycogen content (32) . Another fi nding extracted from our study was the change in the number of mast cells after STZ administration. The number of mast cells located in the portal areas signifi cantly increased after STZ administration. Mast cells are recognized as active participants in mediating a wide range of reactions including autoimmunity, infl ammation and infection. Mast cells are tissuespecifi c and respond to different stimulants in different tissues (33) . Mast cells function by producing secretory granules that release an assortment of bioactive molecules including cytokines, chemokines and proteases as chymase and tryptase, into the surrounding tissues, leading to tissue remodelling. Mast cells are sensitive to many environmental stressors and to those specifi c to diabetes (34, 35) .
In our study, histopathological changes in the liver were signifi cantly improved in the CAPE treatment group. Moreover, we provided many clues about the cytoprotective effect of CAPE by examining hepatocytes by transmission electron microscope. We detected many degenerative cellular alterations, such as numerous vacuolizations including myelinic fi gure formation, pyknotic nuclei with peripheral localization of heterochromatin condensation and mitochondrial elongation. Mitochondria are highly dynamic organelles that mediate essential cell functions such as apoptosis and cell-cycle control in addition to their role as effi cient ATP generators. Changes in mitochondrial morphology are fi rmly regulated and their shape can shift between small, fragmented units and larger networks of elongated mitochondria (36) . We demonstrated that mitochondrial elements elongated after STZ-induced liver injury. In addition, many lysosomes were present within the cytoplasm of hepatocytes and Kupffer cells. Increased lysosome level is also an indicator of the cell injury. Administration of CAPE resulted in a prominent decrease in lysosomal content of the hepatocytes.
In the present study, administration of STZ caused an increase in the lipid peroxidation and decreased the levels of nonenzymatic antioxidants such as SOD and GSH in diabetic rats when compared to normal rats. Decreases in non-enzymatic antioxidants levels might be due to their increased utilization for scavenging free radicals. These fi ndings are in accordance with the previous studies on diabetic animal models (28, (37) (38) (39) . Experimental results have indicated that LPO played a role in tissue injury in STZ-induced diabetic rats (40, 41) . The level of MDA, an end-product of LPO, signifi cantly increased in the liver of the untreated diabetic rats. Thus, increased MDA level in diabetes mellitus suggests that hyperglycaemia induces peroxidative reactions in lipids (42) . Besides, it has been reported that diabetes increased oxidative stress in many organs, especially in the liver (29) . Subsequently increased MDA levels were in concordance with the results of the previous studies on liver (43, 44) . CAPE is a potent antioxidant, which has been reported to prevent oxidative injury secondary to peroxidation (45) . In experimental studies, it has been shown that CAPE protects STZ-induced liver injury (28, 46) .
Within the cell, the reactive oxygen species (ROS) is regulated by antioxidant defense system consisting of non-enzymatic GSH and enzymatic SOD antioxidants (47) . We found signifi cant decreases in the mean tissue SOD activities and GSH levels in the DM group compared to the controls. CAPE has been shown to stimulate several anti-oxidative enzymes, such as SOD and GSH which increase the effi ciency of CAPE as an antioxidant.
It can be concluded that diabetes mellitus increases oxidative stress in hepatic tissue. CAPE inhibits LPO and regulates antioxidant enzymes of diabetic rat liver. The protective role of CAPE might be related with its antioxidant property. The present results suggest that CAPE should be considered in the prevention of oxidative stress in diabetic liver.
